Huadong Medicine Co., Ltd

SZSE:000963.SZ

39.9 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue 40,391.19237,714.58734,563.30133,683.05935,445.69830,663.37427,831.82325,379.66821,727.38318,947.37916,717.98614,579.2311,131.3728,971.8377,824.8726,016.4864,853.4133,942.4553,484.2332,882.4752,325.7112,065.6971,886.4181,617.7311,245.8691,139.095981.131669.742
Cost of Revenue 27,853.82825,682.49723,957.37122,550.48224,086.72321,774.70520,561.71819,219.10616,517.78314,782.66513,341.37911,729.8528,946.6077,288.5376,261.7424,851.4213,814.2523,174.9882,858.42,392.4891,945.3461,752.0441,580.1711,343.7921,032.414948.748830.395604.314
Gross Profit 12,537.36412,032.0910,605.93111,132.57711,358.9758,888.6697,270.1056,160.5625,209.6014,164.7143,376.6072,849.3782,184.7651,683.2991,563.131,165.0651,039.162767.467625.832489.986380.365313.653306.247273.939213.456190.347150.73765.428
Gross Profit Ratio 0.310.3190.3070.3310.320.290.2610.2430.240.220.2020.1950.1960.1880.20.1940.2140.1950.180.170.1640.1520.1620.1690.1710.1670.1540.098
Reseach & Development Expenses 1,161.1961,015.971979.644926.7251,072.937706.041461.754264.095217.744172.539160.852125.23101.989.08200000000000000
General & Administrative Expenses 466.407524.059515.369465.593536.1369.578267.751222.797227.106224.782169.502136.07196.45968.692247.005242.159212.789200.319171.781172.444146.614101.5288.60291.58763.80146.27737.31922.942
Selling & Marketing Expenses 6,645.4116,334.7395,424.0525,983.3795,821.3294,321.3833,728.9113,298.6242,769.462,127.9481,739.7471,437.6951,119.752871.913666.698532.866448.817368.457298.565222.375165.928135.818115.314101.90176.22575.96455.15114.12
SG&A 7,808.8746,858.7985,939.4216,448.9726,357.4294,690.9613,996.6623,521.422,996.5662,352.7311,909.2491,573.7661,216.21940.605913.703775.025661.606568.775470.346394.819312.543237.338203.916193.488140.027122.24192.4737.062
Other Expenses 20.539840.266654.135513.851603.386481.521-16.89741.76339.65617.81720.4077.245.2537.01931.79210.2071.71319.1521.20225.124.26421.31-1.6781.1889.6377.6240.8620.447
Operating Expenses 8,949.5318,715.0357,573.27,889.5488,033.7535,878.5234,871.9234,189.6823,595.7972,833.3532,311.4591,923.3481,465.6381,145.486952.751789.158681.655574.579473.665397.169313.862240.856207.675197.256141.753123.91894.41538.346
Operating Income 3,587.8333,061.4542,855.7143,476.5753,397.0422,909.5712,341.2751,856.4931,382.5111,156.931924.839782.673610.437461.704536.782273.005303.201170.928139.74790.76672.43380.34697.04769.97155.58253.63944.37514.204
Operating Income Ratio 0.0890.0810.0830.1030.0960.0950.0840.0730.0640.0610.0550.0540.0550.0510.0690.0450.0620.0430.040.0310.0310.0390.0510.0430.0450.0470.0450.021
Total Other Income Expenses Net 66.544-30.33-28.179-23.18573.224-37.026-73.803-88.607-193.852-158.492-122.854-138.509-106.264-42.326-45.224-93.596-53.534-44.228-34.646-19.084-15.742-15.261-4.807-10.925-11.54-9.235-15.385-14.771
Income Before Tax 3,654.3763,031.1242,827.5353,453.3913,470.2662,872.5442,324.3781,882.2731,419.9521,172.869942.294787.521612.862495.488565.155282.312303.972169.369139.23594.79973.72979.59694.56768.45962.69159.22943.08713.481
Income Before Tax Ratio 0.090.080.0820.1030.0980.0940.0840.0740.0650.0620.0560.0540.0550.0550.0720.0470.0630.0430.040.0330.0320.0390.050.0420.050.0520.0440.02
Income Tax Expense 619.589498.499488.907543.674544.864477.375436.162346.863267.786230.113194.634166.964126.80799.624117.9154.99177.76548.16653.6349.49333.33223.78927.76812.88413.02612.2018.614.572
Net Income 2,838.8612,499.2142,301.6312,819.8612,813.1192,267.2291,779.5061,446.5921,096.912756.669574.976469.927381.485317.307378.421168.61173.1683.35167.31430.58130.57946.52957.47645.9140.35240.24830.3838.909
Net Income Ratio 0.070.0660.0670.0840.0790.0740.0640.0570.050.040.0340.0320.0340.0350.0480.0280.0360.0210.0190.0110.0130.0230.030.0280.0320.0350.0310.013
EPS 1.621.431.321.611.611.291.020.830.70.480.370.30.240.20.240.110.110.0690.0350.0160.0160.0240.0280.0230.0210.0260.020.006
EPS Diluted 1.621.431.321.611.611.291.020.830.70.480.370.30.240.20.240.110.110.0690.0350.0160.0160.0240.0280.0230.0210.0260.020.006
EBITDA 4,406.1793,897.5583,550.2253,657.7633,892.6383,355.3872,697.6072,252.3641,808.9881,486.8491,218.5431,040.64830.137658.495702.281459.304402.941259.652221.848160.812127.036121.959126.21797.62882.77772.93356.32127.082
EBITDA Ratio 0.1090.1030.1030.1090.110.1090.0970.0890.0830.0780.0730.0710.0750.0730.090.0760.0830.0660.0640.0560.0550.0590.0670.060.0660.0640.0570.04